跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRBESATZ 150/12.5 irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
IRBESATZ 150/12.5 irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet blister pack
Approved
STANDARD
IRBESATZ 150/12.5 irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet blister pack
Sun Pharma ANZ Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4ee248fb7343b129
Company
Sun Pharma ANZ Pty Ltd
Type
Standard
Approval Details
Approval Id
4ee248fb7343b129
Product Name
IRBESATZ 150/12.5 irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet blister pack
Artg Id
190465
Artg Name
IRBESATZ 150/12.5 irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet blister pack
Sponsor
Sun Pharma ANZ Pty Ltd
Company Detail Path
/organization/sun-pharma-anz-pty-ltd
Artg Date
2012-09-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4ee248fb7343b129
Type
Standard
Back to TGA Approvals